Using Machine Learning To Inform Decisions in Drug Discovery: An Industry Perspective
- Darren V. S. Green*Darren V. S. Green*E-mail: [email protected]Department of Molecular Design, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United KingdomMore by Darren V. S. Green
Chapter Views
Citations
Chapter Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.
Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.
Abstract
Modern machine-learning techniques have powered a wave of creative approaches that aim to solve or improve long-standing productivity and attrition problems in drug discovery. While industrial practitioners are keen to embrace new technology, it is important for the community to understand the need to produce actionable decisions for scientists in the field and the implications o for how methods and models conceived, built, validated and their benefits quantified.
Read this chapter
To access this chapter, please review the available access options below.
Get instant access
Purchase Access
Read this chapter for 48 hours. Check out below using your ACS ID or as a guest.
Recommended
Access through Your Institution
You may have access to this chapter through your institution.
Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.
Recommended
Log in to Access
You may have access to this chapter with your ACS ID if you have previously purchased it or have ACS member benefits. Log in below.
-
Purchase access
Purchase this article for 48 hours $48.00 Add to cart Purchase this article for 48 hours Checkout